Takeda Pharmaceutical (TKPHF) Interest Coverage Ratio (2017 - 2026)
Takeda Pharmaceutical (TKPHF) recorded quarterly Interest Coverage Ratio of 0.31 in Q1 2026, up 107.77% quarter-over-quarter from 4.02 in Q4 2025, and up 108.51% on a YoY basis from 0.15 in Q1 2025.
Takeda Pharmaceutical (TKPHF) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 0.31 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 108.51% year-over-year to 0.31; the TTM figure through Mar 2026 stood at 3.22 (up 33.15% YoY), while the FY2026 annual figure was 1.14, up 29.9% from the prior year.
- Interest Coverage Ratio was 0.31 for Q1 2026 at Takeda Pharmaceutical, up from 4.02 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.8 in Q1 2022 to a low of 6.58 in Q3 2024.
- Historically, Interest Coverage Ratio has averaged 2.93 across 5 years, with a median of 3.08 in 2023.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio soared 124.71% in 2022, then slumped 14188.53% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 1.84 in 2022, then sank by 207.75% to 5.67 in 2023, then rose by 29.59% to 3.99 in 2024, then declined by 0.61% to 4.02 in 2025, then jumped by 107.77% to 0.31 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.31 (Q1 2026), 4.02 (Q4 2025), and 3.3 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Takeda Pharmaceutical | - | - | 4.39 Bn | 0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | -4.02 |
| Sep 30, 2025 | -3.30 |
| Jun 30, 2025 | -4.20 |
| Mar 31, 2025 | -3.67 |
| Dec 31, 2024 | -3.99 |
| Sep 30, 2024 | -6.58 |
| Jun 30, 2024 | -2.79 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -5.67 |
| Sep 30, 2023 | -4.32 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | -3.08 |
| Dec 31, 2022 | -1.84 |
| Sep 30, 2022 | -1.94 |
| Jun 30, 2022 | -2.71 |
| Mar 31, 2022 | 0.80 |
| Dec 31, 2021 | -2.49 |
| Sep 30, 2021 | -2.46 |
| Jun 30, 2021 | -3.50 |